View in EDS HTML Full Text PDF Full Text

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.

Saved in:
Bibliographic Details
Title: A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.
Authors: Filho OM; Dana-Farber Cancer Institute, Boston, MA, USA. ometzger@partners.org.; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02468, USA. ometzger@partners.org., Giobbie-Hurder A; Dana-Farber Cancer Institute, Boston, MA, USA., Lin NU; Dana-Farber Cancer Institute, Boston, MA, USA., Faggen M; Dana-Farber Cancer Institute, Boston, MA, USA., Come S; Beth Israel Deaconess Medical Center, Boston, MA, USA., Openshaw T; Eastern Maine Medical Center, Bangor, ME, USA., Constantine M; Dana-Farber Cancer Institute, Boston, MA, USA., Walsh J; Dana-Farber Cancer Institute, Boston, MA, USA., Freedman RA; Dana-Farber Cancer Institute, Boston, MA, USA., Schneider B; Simon Cancer Center at Indiana University, Indianapolis, IN, USA., Burstein HJ; Dana-Farber Cancer Institute, Boston, MA, USA., Mayer EL
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jan; Vol. 185 (1), pp. 135-144. Date of Electronic Publication: 2020 Oct 06.
Publication Type: Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33025482
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Filho+OM%22">Filho OM</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA. ometzger@partners.org.; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02468, USA. ometzger@partners.org.<br /><searchLink fieldCode="AU" term="%22Giobbie-Hurder+A%22">Giobbie-Hurder A</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+NU%22">Lin NU</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Faggen+M%22">Faggen M</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Come+S%22">Come S</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Openshaw+T%22">Openshaw T</searchLink>; Eastern Maine Medical Center, Bangor, ME, USA.<br /><searchLink fieldCode="AU" term="%22Constantine+M%22">Constantine M</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Walsh+J%22">Walsh J</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Freedman+RA%22">Freedman RA</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+B%22">Schneider B</searchLink>; Simon Cancer Center at Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Burstein+HJ%22">Burstein HJ</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mayer+EL%22">Mayer EL</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2021 Jan; Vol. 185 (1), pp. 135-144. <i>Date of Electronic Publication: </i>2020 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33025482
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-020-05928-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 135
    Titles:
      – TitleFull: A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Filho OM
      – PersonEntity:
          Name:
            NameFull: Giobbie-Hurder A
      – PersonEntity:
          Name:
            NameFull: Lin NU
      – PersonEntity:
          Name:
            NameFull: Faggen M
      – PersonEntity:
          Name:
            NameFull: Come S
      – PersonEntity:
          Name:
            NameFull: Openshaw T
      – PersonEntity:
          Name:
            NameFull: Constantine M
      – PersonEntity:
          Name:
            NameFull: Walsh J
      – PersonEntity:
          Name:
            NameFull: Freedman RA
      – PersonEntity:
          Name:
            NameFull: Schneider B
      – PersonEntity:
          Name:
            NameFull: Burstein HJ
      – PersonEntity:
          Name:
            NameFull: Mayer EL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 185
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1